New TEMIS Purchase
TEMIS has acquired U.S.-based advanced analytics and visualization technology firm i3 Analytics. The latter provides a software-as-a-service (SaaS) ‘Biopharma Navigator’ platform that charts the biopharma landscape based on open life sciences data. We found this article on Mr. Web in their article, “TEMIS Buys i3 Analytics.”